Advanced Nootropic
Maximum cognitive enhancement for experienced users
Peak mental performance across memory, focus, and processing speed
Estimated Monthly Cost
$78
Ingredients
5
Why These Combine
A cholinergic design for experienced users: noopept drives acetylcholine demand while citicoline and ALCAR supply it, phosphatidylserine protects neuronal membranes, and Lion's Mane adds slow neuroplasticity. Noopept is the experimental centre — start low, cycle, and pair with choline.
Full Ingredient Protocol
Potent synthetic nootropic enhancing BDNF, NGF, and glutamate signaling
Provides choline backbone to support Noopept's cholinergic demands
Crosses BBB to support mitochondrial energy and acetylcholine synthesis
Maintains neuronal membrane fluidity for faster signal transmission
Disclaimer
Informational only — not medical advice. Noopept is an experimental synthetic compound with limited human safety data and is not an approved medicine in the US/EU (2026); its legal status varies by country. For experienced adults only — not beginners, not during pregnancy/breastfeeding, and not alongside prescription psychiatric, seizure or blood-pressure medication without a doctor's advice. Two specifics worth knowing before you start: do not take the ALCAR in this stack if you are receiving taxane chemotherapy — a randomised trial found it made nerve damage worse, and the effect was still measurable two years later. And noopept without enough choline commonly produces headache and brain fog, which is what the citicoline is here to prevent; if you drop the citicoline, drop the noopept too. Five compounds at once also means that if something goes wrong you will not know which one did it — introduce them about a week apart.
Partner offers
Paid placements. We earn a commission if you buy through these links, at no extra cost to you — it does not change what we write. These are the seller’s own products and claims, not ours, and nothing here is medical advice. Speak to a clinician before starting any supplement.
References
- 1.Neznamov & Teleshova 2009, Neurosci Behav Physiol — Noopept's main human trial was in a clinical (not healthy) population, comparable to piracetam.
- 2.Nakazaki 2021, J Nutr — Citicoline improved memory in healthy older adults.
- 3.Hershman 2018, J Natl Cancer Inst — SWOG S0715, 409 women on adjuvant taxane chemotherapy: ALCAR 1000 mg three times daily made peripheral neuropathy significantly WORSE than placebo (−1.39 points, 95% CI −2.48 to −0.30, P = .01), still measurable two years on. Listed here because ALCAR is in this stack and the trial is the strongest evidence that exists about it. (randomised trial showing harm, in a specific population)
- 4.Mori 2009, Phytother Res — Double-blind trial in 30 adults aged 50–80 with mild cognitive impairment: 3 g/day Hericium erinaceus improved cognitive scores over 16 weeks, and the gain was significantly lost 4 weeks after stopping. (small, and in an impaired population rather than healthy adults)
